The endocrine basis of benign breast disorders

[1]  R. Millis,et al.  Problems in Breast Pathology , 2006, Virchows Archiv.

[2]  R. Hawkins,et al.  Oestrone sulphate, adipose tissue, and breast cancer , 2005, Breast Cancer Research and Treatment.

[3]  R. Santen,et al.  Estrone sulfate: A potential source of estradiol in human breast cancer tissues , 2005, Breast Cancer Research and Treatment.

[4]  O. Sartorius.  The biochemistry of breast cyst fluids and duct secretions , 1995, Breast Cancer Research and Treatment.

[5]  N. Whitworth.  Lactation in humans , 1988, Psychoneuroendocrinology.

[6]  L. Dogliotti,et al.  Apocrine cells in breast cyst fluid and their relationship to cyst type: a morphometric study. , 1988, European journal of cancer & clinical oncology.

[7]  R. Mansel,et al.  ABERRATIONS OF NORMAL DEVELOPMENT AND INVOLUTION (ANDI): A NEW PERSPECTIVE ON PATHOGENESIS AND NOMENCLATURE OF BENIGN BREAST DISORDERS , 1987, The Lancet.

[8]  D. Rose,et al.  A comparison of serum and breast duct fluid‐immunoassayable prolactin and growth hormone with bioassayable lactogenic hormones in healthy women and patients with cystic breast disease , 1987, Cancer.

[9]  J. Bonneterre,et al.  Prognostic significance of prolactin receptors in human breast cancer. , 1987, Cancer research.

[10]  M. Massobrio,et al.  Breast duct fluid dehydroepiandrosterone sulphate in fibrocystic disease. , 1987, European journal of cancer & clinical oncology.

[11]  L. Murphy,et al.  Expression of the gene encoding a prolactin-inducible protein by human breast cancers in vivo: correlation with steroid receptor status. , 1987, Cancer research.

[12]  R. Dickson,et al.  Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. , 1987, Endocrine reviews.

[13]  J. Russo,et al.  Development of the Human Mammary Gland , 1987 .

[14]  L. Murphy,et al.  Biological actions of prolactin in human breast cancer. , 1987, Recent progress in hormone research.

[15]  L. Dogliotti,et al.  Cations and dehydroepiandrosterone-sulfate in cyst fluid of pre- and menopausal patients with gross cystic disease of the breast. Evidence for the existence of subpopulations of cysts. , 1986, European journal of cancer & clinical oncology.

[16]  J. Deslypere,et al.  Steroid dynamics in the normal and carcinomatous mammary gland. , 1986, Journal of steroid biochemistry.

[17]  L. Dogliotti,et al.  Prolactin Dynamics after Acute Stimulation with Thyrotropin‐Releasing Hormone and Domperidone in Women with Fibrocystic Disease of the Breast , 1986 .

[18]  R. Santen,et al.  Enzymatic Control of Estrogen Production in Human Breast Cancer: Relative Significance of Aromatase versus Sulfatase Pathways , 1986, Annals of the New York Academy of Sciences.

[19]  A. V. Landeghem,et al.  Uptake and Concentration of Steroid Hormones in Mammary Tissues , 1986, Annals of the New York Academy of Sciences.

[20]  T. Oka,et al.  4 Paracrine regulation of mammary gland growth , 1986 .

[21]  T. Oka,et al.  Paracrine regulation of mammary gland growth. , 1986, Clinics in endocrinology and metabolism.

[22]  P. Eskildsen,et al.  Release of prolactin, thyrotropin, and growth hormone in women with cyclical mastalgia and fibrocystic disease of the breast , 1985, Cancer.

[23]  M. Fleisher,et al.  Plasma steroid-binding proteins in the cysts of gross cystic disease of the breast. , 1985, The Journal of clinical endocrinology and metabolism.

[24]  K. Griffiths,et al.  Evaluation of luteal-phase salivary progesterone levels in women with benign breast disease or primary breast cancer. , 1985, European journal of cancer & clinical oncology.

[25]  L. Dogliotti,et al.  Prolactin and thyrotropin response to thyrotropin-releasing hormone in premenopausal women with fibrocystic disease of the breast. , 1985, Hormone research.

[26]  P. Stell,et al.  Serum progesterone concentration during the luteal phase in women with benign breast disease. , 1984, European journal of cancer & clinical oncology.

[27]  L. Dogliotti,et al.  Thyroid hormone levels in human breast cyst fluid. , 1984, Acta endocrinologica.

[28]  M. Breckwoldt,et al.  Serum Prolactin Levels in Patients With Fibrocystic Breast Disease , 1984, Obstetrics and gynecology.

[29]  A. Herz,et al.  Endocrine Actions of Opioids , 1984, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[30]  G. Muccioli,et al.  Presence and characterization of prolactin receptors in human benign breast tumours. , 1984, European journal of cancer & clinical oncology.

[31]  R. Newcombe,et al.  Prolactin response to thyrotropin‐releasing hormone stimulation and dopaminergic inhibition in benign breast disease , 1984, Cancer.

[32]  A. D'ercole,et al.  Insulin and insulin-like growth factors/somatomedins in fetal and neonatal development. , 1984, Clinics in endocrinology and metabolism.

[33]  I. Cooke,et al.  Luteal-phase insufficiency , 1984 .

[34]  W. Miller,et al.  The morphological basis of human breast cyst populations , 1983, The British journal of surgery.

[35]  A. Forrest,et al.  Classification of human breast cysts according to electrolyte and androgen conjugate composition. , 1983, Clinical oncology.

[36]  R. Frairia,et al.  Evidence for a transcortin-like component in human breast cyst fluid. , 1983, Clinica chimica acta; international journal of clinical chemistry.

[37]  R. Greenblatt,et al.  Fibrocystic "disease" of the breast. , 1982, The New England journal of medicine.

[38]  A. Pontiroli,et al.  Effects of naloxone on prolactin, luteinizing hormone, and cortisol responses to surgical stress in humans. , 1982, The Journal of clinical endocrinology and metabolism.

[39]  C. Bodian,et al.  Breast Carcinoma: Risk and Detection , 1981 .

[40]  M. Fleisher,et al.  Steroid hormone accumulation in human breast cyst fluid. , 1981, Cancer research.

[41]  R. Noble,et al.  A new sensitive and specific bioassay for lactogenic hormones: measurement of prolactin and growth hormone in human serum. , 1980, The Journal of clinical endocrinology and metabolism.

[42]  W. Miller,et al.  Dehydroepiandrosterone sulphate in breast secretions. , 1980, Journal of steroid biochemistry.

[43]  F. Halberg,et al.  Circadian mesor-hyperprolactinemia in fibrocystic mastopathy. , 1979, The American journal of medicine.

[44]  J. O'brien,et al.  "EXHAUSTED" PLATELETS CONTINUE TO CIRCULATE , 1978, The Lancet.

[45]  W. Malarkey,et al.  Twenty-four-hour preoperative endocrine profiles in women with benign and malignant breast disease. , 1977, Cancer research.

[46]  E. N. Cole,et al.  Serum prolactin concentrations in benign breast disease throughout the menstrual cycle. , 1977, European journal of cancer.

[47]  I. Mowszowicz,et al.  Inadequate corpus luteal function in women with benign breast diseases. , 1977, The Journal of clinical endocrinology and metabolism.

[48]  H. Nagasawa,et al.  Prolactin and murine mammary tumorigenesis: a review. , 1977, Cancer research.

[49]  F. Kuttenn,et al.  Mastopathies bénignes: étude hormonale chez 125 malades. , 1977 .

[50]  J. Meites,et al.  Prolactin and estrogen dependency of rat mammary cancers at early and late stages of development. , 1976, Cancer research.

[51]  R. Sellwood,et al.  Sex hormones in breast disease , 1975, The British journal of surgery.

[52]  D. Parker,et al.  Sleep-related, nychthermeral and briefly episodic variation in human plasma prolactin concentrations. , 1973, The Journal of clinical endocrinology and metabolism.